AI and Empathy, Transforming Veterinary Medicine with Dr. Christopher PinardThe team welcomes Dr. Christopher Pinard, a board-certified veterinary oncologist and AI entrepreneur. The conversation dives deep into the intersection of artificial intelligence and oncology, exploring how AI is revolutionizing cancer care for pets, improving accessibility, and personalizing treatment. Dr. Pinard shares insights from his research, the challenges of integrating AI into veterinary practice, and the importance of empathy in both human and machine interactions. The hosts and guests discuss the future of veterinary medicine, the role of data, trust, and regulation, and offer practical advice for practitioners and pet owners navigating this rapidly evolving landscape.

00:00 – Empathy in AI: The Surprising First Response 00:25 – The Future of Pet Owners and AI Tools

01:05 – Introducing Dr. Christopher Pinard

02:00 – The Evolution of Oncology in Veterinary Medicine 03:00 – Chris's Journey: From Vet School to AI Entrepreneur

05:00 – Translational Medicine: Lessons from Human Oncology

07:00 – AI in Research: Protein Folding and Drug Development

10:00 – How AI is Accelerating Cancer Research

13:00 – Personalized Care and Predictive Oncology

16:00 – Remote Consultations and 3D Tumor Scanning 20:00 – Computer Vision and Automated Tumor Detection 25:00 – Trust, Data, and the Challenges of AI Adoption 30:00 – Regulation, Benchmarks, and Transparency in AI Tools

35:00 – The Future of Veterinary Practice: Collaboration and Education

40:00 – Final Takeaways and the Call for AI Literacy

This episode of The Veterinary AI Brief gets real the moment a client in a euthanasia consult says, "I'm going to ask ChatGPT what to do." From that human, high-stakes scene, guest Dr. Andy Roark (Uncharted Veterinary Conference; longtime pulse-check for practitioners) joins hosts Robert Sanchez, Adam Little and Aaron Massecar to unpack what AI is doing to the identity of general practice - and how to keep care human. We start with the U.K. CMA's push for price transparency and ask whether bottom-up tech in North America will force similar change. Rourke argues the danger isn't transparency itself; it's commoditization - when "a neuter is just a neuter" and nuance disappears. He lays out a vivid framework: use AI as an accelerator, not a crutch; beware the "easy-button" path that atrophies clinical judgment; expect a cultural and economic pushback phase driven by misapplication and weak ROI; and prepare for unpredictable watershed moments that shape public comfort with AI.